What fools these mortals be: The Tipline for 8 September 2020

We hope you all had a splendid three-day weekend. Before everyone logged off on Friday, the Federal Trade Commission announced that it approved a final order settling charges that AbbVie’s $63 billion acquisition of Allergan would violate federal antitrust law. Commissioner Rohit Chopra took another dig at the settlement, which he voted against back in May. “Public input received during the comment period from across the country also called into question the appropriateness of this decision, but the FTC went ahead anyway,” he tweeted.


Get unlimited access to all Global Competition Review content